398 related articles for article (PubMed ID: 31547587)
1. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer.
Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587
[TBL] [Abstract][Full Text] [Related]
2. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway.
Li XJ; Park ES; Park MH; Kim SM
Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
4. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
5. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
6. Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer.
Tang Y; Fang G; Guo F; Zhang H; Chen X; An L; Chen M; Zhou L; Wang W; Ye T; Zhou L; Nie P; Yu H; Lin M; Zhao Y; Lin X; Yuan Z; Jiao S; Zhou Z
Cancer Cell; 2020 Jul; 38(1):115-128.e9. PubMed ID: 32589942
[TBL] [Abstract][Full Text] [Related]
7. RhBMP-2 Activates Hippo Signaling through RASSF1 in Esophageal Cancer Cells.
Kim SM; Ye S; Rah SY; Park BH; Wang H; Kim JR; Kim SH; Jang KY; Lee KB
Sci Rep; 2016 May; 6():26821. PubMed ID: 27230238
[TBL] [Abstract][Full Text] [Related]
8. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
9. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
10. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
Li L; Zhao J; Huang S; Wang Y; Zhu L; Cao Y; Xiong J; Deng J
Gene; 2018 Jan; 641():240-247. PubMed ID: 29045821
[TBL] [Abstract][Full Text] [Related]
11. The Hippo pathway as a drug target in gastric cancer.
Qiao Y; Li T; Zheng S; Wang H
Cancer Lett; 2018 Apr; 420():14-25. PubMed ID: 29408652
[TBL] [Abstract][Full Text] [Related]
12. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
Subramaniam D; Ponnurangam S; Ramalingam S; Kwatra D; Dandawate P; Weir SJ; Umar S; Jensen RA; Anant S
Cells; 2021 Jun; 10(7):. PubMed ID: 34206989
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
14. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
15. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
16. Discovery of
Niu JB; Hua CQ; Liu Y; Yu GX; Yang JJ; Li YR; Zhang YB; Qi YQ; Song J; Jin CY; Zhang SY
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1715-1731. PubMed ID: 34425716
[TBL] [Abstract][Full Text] [Related]
17. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
[TBL] [Abstract][Full Text] [Related]
18. Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress.
Wang Y; Li J; Gao Y; Luo Y; Luo H; Wang L; Yi Y; Yuan Z; Jim Xiao ZX
Redox Biol; 2019 Sep; 26():101233. PubMed ID: 31212215
[TBL] [Abstract][Full Text] [Related]
19. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.
Deng J; Lei W; Xiang X; Zhang L; Lei J; Gong Y; Song M; Wang Y; Fang Z; Yu F; Feng M; Sun Z; Chen J; Zhan Z; Xiong J
Oncotarget; 2016 Mar; 7(9):10037-50. PubMed ID: 26840256
[TBL] [Abstract][Full Text] [Related]
20. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
